SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X, a Bitcoin-native meme coin launched via the Runes protocol, is trending as the community rallies around its fair distribution and potential to drive utility on the Bitcoin network.  Many see it as a cultural movement and are actively discussing its unique position compared to other meme coins like $DOGE.X. Some community members also highlight the accumulation of $DOG.X by a publicly listed company.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the board considers a large compensation package for Musk tied to ambitious AI and robotaxi goals, sparking debate about the company's future and Musk's performance. The community is discussing the feasibility of these targets and the potential impact on the stock, with some questioning Tesla's valuation and competitive position, especially against Chinese EV manufacturers. Recent news around Robotaxi and a Tesla Megapack project are also adding to the conversation.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

$SNAP is trending as traders buzz about potential AI integration and buyout rumors, with some pointing to activity on WallStreetBets and X as a potential catalyst. Community members are actively speculating on potential acquirers and comparing valuations to competitors like Reddit. Technical analysis and short squeeze potential are also being discussed.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

Seres Therapeutics is trending amid speculation of a potential acquisition or strategic partnership following a recent CEO transition and board shake-up. Fueling the discussion is a rumor of a Nestle buyout offer, leading to community debate about its validity and the potential impact on shareholder value. With high short interest, many anticipate a possible short squeeze if positive news emerges, while others express caution due to the company's history.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas (BOIL) is trending as traders debate its next move amid fluctuating natural gas prices and storage levels. Community discussions revolve around technical analysis, potential bullish or bearish signals, and the impact of weather forecasts on demand. Some traders anticipate a rebound, while others foresee further declines, creating a mixed sentiment around BOIL's short-term prospects.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

ProShares Short Dow30 ($DOG) is trending as the community rallies behind Dog (Bitcoin), touting its fair launch and strong community as key differentiators in the memecoin space. Many see $DOG as the 'people's bitcoin' and are actively promoting it on social media platforms, emphasizing its community-driven nature and potential for growth within the Bitcoin ecosystem. Some users are also discussing the ProShares ETF $DOG and how they are using it as downside protection.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is trending as investors anticipate the impact of a recently announced large government contract with Germany and other potential deals, while monitoring upcoming earnings. The community is buzzing about the company's decision to announce earnings from the floor of the NYSE, speculating it signals major news, possibly a crazy good earnings beat, positive guidance, or even a buyout, and assessing the potential for a breakout above key resistance levels. With institutional ownership increasing, attention is turning towards Planet Labs' growth potential within the broader space and defense technology sector.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor ($OPEN) is trending as retail investors rally behind potential catalysts like a new CEO announcement and speculation around future interest rate cuts. Community members are actively discussing potential gamma squeezes, the influence of activist investor Eric Jackson, and celebrity endorsements. Some are drawing comparisons to past meme stock rallies, while others express concern about the company's fundamentals.

American Bitcoin Corp. is a bitcoin accumulation platform focused on building America's bitcoin infrastructure platform. It delivers institutional-grade exposure to bitcoin through an industry-first business model that integrates scaled self-mining operations with disciplined accumulation strategies. The company was founded on October 22, 2020 and is headquartered in Miami, FL.

American Bitcoin Corp. - Ordinary Shares - Class A

American Bitcoin Corp.

American Bitcoin Corp. ($ABTC) is trending due to its recent NASDAQ debut and ties to the Trump family (Eric Trump), sparking significant retail interest. Community members are actively discussing the stock's potential as a Bitcoin play and its low float, while others are wary of dilution risks and the company's valuation. Bullish sentiment is fueled by potential short squeeze setups, while bearish arguments focus on market cap and asset valuation relative to Bitcoin holdings.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as discussions revolve around its potential for a buyout, with some highlighting the company's buyback program as a possible price floor. Community members are analyzing institutional ownership and revenue projections while expressing frustration with the stock's recent performance relative to other biotech companies. There's also anticipation for upcoming catalysts, like subq trial updates and management commentary, that could drive a positive shift.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AMAT Rides on the Strength in Semiconductor Systems: Will it Last?

Applied Materials posts record Q3 revenues on Semiconductor Systems strength, but softer Q4 guidance raises questions on momentum.

Lattice (LSCC) Up 18.9% Since Last Earnings Report: Can It Continue?

Lattice (LSCC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Shares of Fremont, California-based chip-equipment maker Lam Research Corp. (LRCX) traded down about 3% in the early premarket session, after they fell nearly 3.80% last Friday.Tuesday’s slide is attributable to the broader market negativity, as seen by the decline in the U.S. stock futures and an analyst’s downgrade.Morgan Stanley analysts downgraded the&nbsp;<a href="https://stocktwits.com/symbol/LRCX">Lam Research stock</a> from ‘Equal-Weight’ to ‘Underweight’ in a note released on Monday, Investing.com&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.investing.com/news/analyst-ratings/morgan-stanley-downgrades-lam-research-stock-on-slowing-growth-outlook-93CH-4217821">reported.</a> The analysts reduced the price target for the stock to $92 from $94, implying about 8% downside from current levels.The research firm’s pessimism toward the stock stemmed from its expectations that Lam Research’s growth drivers in China and the NAND memory markets will slow significantly after two years of strong growth in 2024-2025.The firm expects shipment growth to decelerate to 3% in 2026 from 82% in 2025. While acknowledging that Lam has had a strong presence in the NAND segment, gaining 25 percentage points of market share over the past decade, the firm said the company’s end market lacks the robustness needed to drive further growth for both Lam and the NAND wafer fabrication equipment (WFE) sector.On Stocktwits, retail sentiment toward Lam Research stock has remained ‘bearish’ since a month ago. The latest sentiment meter reading was at 40/100 af early Tuesday. The message volume on the stream was at ‘low’ levels.<figure class="image"><img style="aspect-ratio:623/53;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_02_at_5_35_55_AM_png_08f25003a1.webp" alt="Screenshot 2025-09-02 at 5.35.55 AM.png" width="623" height="53"><figcaption>LRCX sentiment and message volume as of 5:30 a.m. ET, Sept. 2 | source: Stocktwits</figcaption></figure>The stock has gained nearly 40% year-to-date (YTD). The Koyfin-compiled average analysts’ price target for the stock implied about 9% upside from current levels.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-nvidia-s-slide-may-not-be-over/chv6ZblRdnL">Why Nvidia’s Slide May Not Be Over: Stock Faces 4th Straight Day Of Losses</a>

In this photo illustration, a person holds a smartphone displaying the logo of Lam Research Corporation (NASDAQ: LRCX) on July 28, 2025, in Chongqing, China. 

Why Lam Research Stock Is Down 3% In Today’s Premarket

Morgan Stanley stated that Lam Research’s end market lacks the robustness necessary to drive further growth for both Lam and the NAND wafer fabrication equipment (WFE) sector.

Equity

Morgan Stanley stated that Lam Research’s end market lacks the robustness necessary to drive further growth for both Lam and the NAND wafer fabrication equipment (WFE) sector.


Lam Research (LRCX) Sees a More Significant Dip Than Broader Market: Some Facts to Know

In the closing of the recent trading day, Lam Research (LRCX) stood at $100.11, denoting a -3.82% move from the preceding trading day.

Why Is Lam Research (LRCX) Up 9.8% Since Last Earnings Report?

Lam Research (LRCX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The U.S. announced on Friday plans to tighten restrictions on global chipmakers operating in China, revoking authorizations that allowed Samsung Electronics, SK Hynix, and Intel (INTC) to receive American semiconductor manufacturing equipment in the country.According to a notice in the Federal Register, the restrictions take effect in 120 days. Intel continues to produce wafers in China even though it sold its Dalian NAND plant to SK Hynix in 2021. Now, the companies will need to obtain licenses to buy the equipment in China.&nbsp;<a href="http://stocktwits.com/symbol/INTC">Intel’s stock price</a> edged 1% lower in morning trade. The broader market is also trending lower after it was&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/us-pce-index-july-2025/chtTiOCRdNX">reported</a> that the personal consumption expenditure (PCE) index rose 2.6% in July, higher than the Federal Reserve’s 2% target. On Stocktwits, retail sentiment around the former PC giant trended lower but remained in ‘bullish’ territory as chatter dipped to ‘normal’ from ‘high’ levels over the past day.&nbsp;The rule change could weigh on sales by U.S. equipment makers KLA Corp. (KLAC), Lam Research (LRCX), and Applied Materials (AMAT). At the same time, it may create openings for Chinese suppliers and benefit Micron (MU), a key U.S. rival to Samsung and SK Hynix in the memory market.<a href="https://stocktwits.com/symbol/LRCX">Lam Research’s stock</a> dropped nearly 3.5% in morning trade, while <a href="https://stocktwits.com/symbol/KLAC">KLA’s stock</a> fell 2.2% and <a href="https://stocktwits.com/symbol/AMAT">shares of Applied Materials</a> were down 2%. However, retail sentiment on Stocktwits around Lam Research improved to ‘bearish’ from ‘extremely bearish’ territory over the past day. Retail sentiment around Applied Materials and KLA Corp. continued to trend in ‘bearish’ territory.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/fannie-mae-freddie-mac-ipo-plans-face-democratic-pushback-on-mortgage-rate-risks/chtTihmRdNg">Fannie Mae, Freddie Mac IPO Plans Face Democratic Pushback On Mortgage Rate Risks: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Intel logo is displayed on a sign in front of Intel headquarters on July 16, 2025 in Santa Clara, California. (Photo by Justin Sullivan/Getty Images)

US Revokes Intel, Samsung, SK Hynix Waivers On China Chip Equipment

According to a notice in the Federal Register, the restrictions take effect in 120 days and the companies will now need to obtain licenses to buy the equipment in China.

LRCX's Akara Etch Wins Gain Momentum: Can it Expand DRAM Share?

Lam Research's Akara etch tool gains early traction in DRAM production, positioning LRCX to expand its memory market share.

AMAT's Etch Business Crosses $1B: Can DRAM Momentum Continue?

Applied Materials' etch business surpasses $1B in Q3 as DRAM demand for AI workloads fuels momentum and future market share gains.

Newly listed options deliver another trading tool to express high conviction views on growth stocks including Astera Labs and MongoDBNEW YORK, Aug. 26, 2025 /PRNewswire/ -- <a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4494959-1&amp;h=2649503750&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=Tradr+ETFs">Tradr ETFs</a>,&nbsp;a provider of ETFs designed for sophisticated investors and professional traders, today announced that options trading is now available on its four newest leveraged ETFs: the Tradr 2X Long ALAB Daily ETF (Cboe: LABX), the Tradr 2X Long DDOG Daily ETF (Cboe: DOGD), the Tradr 2X Long MDB Daily ETF (Cboe: MDBX), and the Tradr 2X Long LRCX Daily ETF (Cboe: LRCU).The four ETFs, all first-to-market products launched in August, allow traders to express their high conviction views on underlying stocks with strong ties to the AI data center boom: Astera Labs (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/options-trading-available-on-recently-launched-tradr-etfs-labx-dogd-mdbx-and-lrcu-302538420.html#financial-modal">ALAB</a>), Datadog (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/options-trading-available-on-recently-launched-tradr-etfs-labx-dogd-mdbx-and-lrcu-302538420.html#financial-modal">DDOG</a>), MongoDB (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/options-trading-available-on-recently-launched-tradr-etfs-labx-dogd-mdbx-and-lrcu-302538420.html#financial-modal">MDB</a>) and Lam Research (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/options-trading-available-on-recently-launched-tradr-etfs-labx-dogd-mdbx-and-lrcu-302538420.html#financial-modal">LRCX</a>)."The launch of options trading on the four newest Tradr ETFs gives investors yet another tool to help navigate one of the most transformative investment themes of our time," said Matt Markiewicz, Head of Product and Capital Markets at Tradr ETFs.For detailed information on Tradr ETFs and the significant risks involved with leveraged ETFs, please visit <a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4494959-1&amp;h=791121047&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=www.tradretfs.com">www.tradretfs.com</a>.About Tradr ETFs <a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4494959-1&amp;h=2649503750&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=Tradr+ETFs">Tradr ETFs</a>&nbsp;are designed for sophisticated investors and professional traders&nbsp;who are looking to express high conviction investment views. The strategies include leveraged and inverse ETFs that seek short or long exposure to actively traded stocks and ETFs.IMPORTANT RISK INFORMATIONTradr ETFs are for sophisticated investors and professional traders with high conviction views and are very different from most other ETFs. The Funds are intended to be used as short-term trading vehicles and pursue leveraged investment objectives, which means they are riskier than alternatives that do not use leverage because the Funds magnify the performance of their underlying security. The volatility of the underlying security may affect a Fund's return as much as, or more than, the return of the underlying security.Investors in the fund should: (a) understand the risks associated with the use of leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively monitor and manage their investment. Fund performance will likely be significantly different than the benchmark over periods longer than the specified reset period and the performance may trend in the opposite direction than its benchmark over periods other than that period.Leverage increases the risk of a total loss of an investor's investment, may increase the volatility of the Funds, and may magnify any differences between the performance of the Funds and their reference security. The Funds seek leveraged investment results for a specific period (daily, monthly or quarterly). The exact exposure of an investment in the Fund intra-period will depend upon the movement of the reference security from the end of the prior period until the time of investment by the investor.The Fund will not attempt to position its portfolio to ensure it does not gain or lose more than a maximum percentage of its net asset value on a given trading day. As a consequence, investors in a Fund that seeks two times daily performance would lose all of their money if the Fund's underlying security moves more than 50% in a direction adverse to the Fund on a given trading day. Principal risks and other important risks may be found in the prospectus. Past performance does not guarantee future results.ETFs involve risk including possible loss of the full principal value. There is no assurance that the Fund will achieve its investment objective.ETF shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns.Investors should carefully consider the investment objectives, risks, charges and expenses of the Funds. This and other important information about the Fund is contained in the Prospectus, which can be obtained by visiting <a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4494959-1&amp;h=791121047&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=www.tradretfs.com">www.tradretfs.com</a>. The Prospectus should be read carefully before investing.Distributed by ALPS Distributors, Inc, which is not affiliated with AXS Investments or its Tradr ETFs. AXI000737SOURCE Tradr ETFs

Options Trading Available on Recently Launched Tradr ETFs: LABX, DOGD, MDBX and LRCU

Newly listed options deliver another trading tool to express high conviction views on growth stocks including Astera Labs and MongoDB

Options Trading Available on Recently Launched Tradr ETFs

Others

ASML Sees 30% EUV Growth in 2025: Is Demand Sustainable Through 2026?

ASML Holding expects EUV sales to surge 30% in 2025 on AI and memory demand, but macro risks cloud the outlook for 2026.

Lam Research Corp. engages in the design, manufacture, marketing, refurbishment, and provision of semiconductor processing equipment used in the fabrication of integrated circuits. It operates through the following geographical segments: United States, China, Europe, Japan, Korea, Southeast Asia and Taiwan. The company was founded by David K. Lam in 1980 and is headquartered in Fremont, CA.

LRCX
Lam Research Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LRCX News

LRCX Lam Research Corp.